BOSTON, Apr 21, 2010 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today responded
to public comments made yesterday by NuVasive, Inc. during their first
quarter earnings call stating that a dispute has been initiated against
the Company. The comments indicated that the dispute apparently concerns
the defense of patents acquired by NuVasive.
NuVasive has not been in contact with the Company, nor has the Company
received any information from NuVasive regarding the dispute.
"At best, we find both the NuVasive announcement and the forum for the
announcement questionable. We prefer to compete in the marketplace so
that we can continue to bring next generation technologies to the market
for the benefit of patients and surgeons who treat them. It is
Orthofix's policy to respect the intellectual property rights of others,
and we are prepared to vigorously defend ourselves against any
allegations to the contrary," stated Orthofix's CEO, Alan Milinazzo.
About Orthofix International N.V.
Orthofix International N.V., a global medical device company, offers a
broad line of minimally invasive surgical, as well as non-surgical,
products for the spine, orthopedic, and sports medicine market sectors
that address the lifelong bone-and-joint health needs of patients of all
ages, helping them achieve a more active and mobile lifestyle.
Orthofix's products are widely distributed around the world to
orthopedic surgeons, hospitals and patients via Orthofix's sales
representatives and its subsidiaries, including Breg, Inc. and
Blackstone Medical, Inc. In addition, Orthofix is collaborating in R&D
partnerships with leading institutions such as the Musculoskeletal
Transplant Foundation, the Orthopedic Research and Education Foundation,
the Musculoskeletal Transplant Foundation, and the National Osteoporosis
Institute. For more information about Orthofix, please visit www.orthofix.com.
SOURCE: Orthofix International N.V.
Orthofix International N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com
Copyright Business Wire 2010